VEN treatment can significantly inhibit the NE-induced Akt activation and VEGF expression in vitro and the NE-induced tumor angiogenesis and tumor growth in vivo, with no significant changes by only VEN treatment. The gene discussed is VEGFA; the disease is neoplasm.